EVAX,Evaxion Biotech A/S | Healthcare

Healthcare

EVAX

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Evaxion Biotech A/SEVAX

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies.

The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase 1/2a trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers.

Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases.

Evaxion Biotech A/S was incorporated in 2008 and is based in Hørsholm, Denmark.

Latest News >

Campbell Soup dropping 'soup' in name to become 'The Campbell's Company'

Sep 11, 2024

(Reuters) - Campbell Soup ( CPB ) is dropping soup from its name to become The Campbell's Company, CEO Mark Clouse said on Tuesday, a pivot symbolizing the company's shift to other packaged food such as jarred sauces like Rao's and Goldfish snacks. Clouse told Wall Street at its investor day that Campbell's is focusing on 16 top brands across...

IZEA Worldwide Partners With GP Investments, Enhances Board

Sep 11, 2024

11:10 AM EDT, 09/10/2024 (MT Newswires) -- IZEA Worldwide ( IZEA ) said Tuesday it formed a partnership with GP Investments to launch a series of value-enhancing initiatives and enhanced its board with the appointment of two GP Investments executives. Antonio Bonchristiano and Rodrigo Boscolo of GP Investments are joining IZEA's ( IZEA ) board, the company said. The company's...

AI search startup Glean announces new funding at $4.6 bln valuation

Sep 11, 2024

Sept 10 (Reuters) - Enterprise AI search firm Glean raised over $260 million in a new funding round, doubling its valuation to $4.6 billion, as investor interest in startups that deploy artificial intelligence-powered services continues to grow. The Series E funding round, led by Altimeter and DST Global, has boosted Glean's valuation from its previous $2.2 billion in February. The...

Boeing delivers 40 jets in August, up 5 from a year ago

Sep 11, 2024

Sept 10 (Reuters) - Boeing ( BA ) said on Tuesday it delivered 40 commercial jets in August, up five from the same month in 2023 when it struggled with a manufacturing defect on its 737 MAX, as the U.S. planemaker eyes higher output under new CEO Kelly Ortberg. Boeing ( BA ) has pledged to boost production of its...